Studies on ovarian cancer cells demonstrated that TNF-β overexpression is commonly found in different ovarian cancer subtypes, and that the lymphotoxin-β receptor is expressed ubiquitously in ovarian cancer cells as well as cancer-associated fibroblasts. Here, LTBR is linked to ovarian cancer.